Two studies researched the effect of GnRHa in the endometrium of patients with fibroids and indicated an anti-angiogenic effect, as they showed a decrease in MVD, macrophage infiltration, MCP-1, and endothelial, epithelial, and stromal cell proliferation [41,42]. This evidence concerns the gene CCL2 and leiomyoma.